Failure of double protease inhibitor therapy as a salvage therapy for HIV-infected patients resistant to conventional triple therapy.

European journal of medical research

Volumn 4, Issue 7, 1999, Pages 271-274

  Rockstroh, J K ^a   Altfeld, M ^a   Kupfer, B ^a   Kaiser, R ^a   Fatkenheuer G ^a   Salzberger, B ^a   Schneweis, K E ^a   Spengler, U ^a  

^a Department of Medicine ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NELFINAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE;

ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; DRUG COMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; SALVAGE THERAPY; VIRUS LOAD;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; NELFINAVIR; REVERSE TRANSCRIPTASE INHIBITORS; SALVAGE THERAPY; SAQUINAVIR; STAVUDINE; VIRAL LOAD;

EID: 0033612598     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)